Yahoo Web Search

Search results

1. Xilio Therapeutics, Inc.

   NasdaqGS: XLO

   1.0900

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.0800 (+7.92%)

   At close: Fri. Apr 26, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1.0400
     High	1.1100
     Low	1.0400

   • Mkt Cap	40.23M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	1.0100
     52 Wk. Low	0.4900
     52 Wk. High	3.3000

   More about XLO

   Top stories

   • ADMA
     +1.71%
   • GILD
     +0.23%
   • ANIP
     +0.63%
   • XLO

   Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat

   Yahoo Finance · 1 day ago

   

   Related stocks

   • CADL
     Candel Therapeutics, Inc.
     CADL
     6.39
     -0.62%
   • TYRA
     Tyra Biosciences, Inc.
     TYRA
     15.67
     +3.71%
   • HOWL
     Werewolf Therapeutics, Inc.
     HOWL
     6.75
     +8.70%
   • IMRX
     Immuneering Corporation
     IMRX
     1.4700
     +2.80%
   • RLYB
     Rallybio Corporation
     RLYB
     1.7000
     +3.03%

   More on Yahoo Finance

2. finance.yahoo.com › quote › XLOXilio Therapeutics, Inc. (XLO) Stock Price, News, Quote ...

   finance.yahoo.com › quote › XLO

   • Cached

   Find the latest Xilio Therapeutics, Inc. (XLO) stock quote, history, news and other vital information to help you with your stock trading and investing.

3. www.google.com › finance › quoteXilio Therapeutics Inc (XLO) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest Xilio Therapeutics Inc (XLO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

4. www.marketwatch.com › investing › stockXLO Stock Price | Xilio Therapeutics Inc. Stock Quote (U.S ...

   www.marketwatch.com › investing › stock

   4 days ago · Medicenna Therapeutics Corp. -6.71%. $114.21M. XLO | Complete Xilio Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

   • 1 Month: 62.70%
   • 5 Day: 20.37%

   • 3 Month: 79.38%
   • YTD: 136.36%

5. www.nasdaq.com › market-activity › stocksXilio Therapeutics, Inc. Common Stock (XLO) Stock Price ...

   www.nasdaq.com › market-activity › stocks

   • Cached

   Xilio Therapeutics, Inc. Common Stock (XLO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

6. People also ask

   Is XLO stock a good buy?

   • According to one analyst, the rating for XLO stock is "Strong Buy" and the 12-month stock price forecast is $7.0. WALTHAM, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies fo...

   Xilio Therapeutics, Inc. (XLO) - Stock Analysis

   stockanalysis.com/stocks/xlo/

   See all results for this question

   What is XLO?

   • XLO is a summary, a simplification that retains the essence, of the word excello. Because with XLO, we wanted to make everything we had learned and experienced about change easily accessible. The greatest possible competence, in the shortest possible time and with the greatest amount of fun has been the goal and motivation from the start.

   Welcome to XLO Change Academy - XLO Change Academy

   xlo.academy/en/

   See all results for this question

   Who owns xilio Therapeutics Inc?

   • Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA. XLO | Complete Xilio Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

   XLO Stock Price | Xilio Therapeutics Inc. Stock Quote (U.S.: Nasdaq

   www.marketwatch.com/investing/stock/xlo

   See all results for this question

   What is xilio xtx101?

   • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 1 clinical trial for patients with advanced solid tumors.

   Xilio Therapeutics, Inc. (XLO) - Yahoo Finance

   finance.yahoo.com/quote/XLO

   See all results for this question

7. stockanalysis.com › stocks › xloXilio Therapeutics, Inc. (XLO) Stock Price, Quote & News ...

   stockanalysis.com › stocks › xlo

   • Cached

   2 days ago · About XLO. Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 1 clinical trial for patients with advanced solid tumors.

   • EPS (ttm): 2.78
   • Net Income (ttm): 76.40M

   • Market Cap: 33.05M
   • Shares Out: 27.54M

8. seekingalpha.com › symbol › XLOXilio Therapeutics, Inc. (XLO) Stock Price, Quote, News ...

   seekingalpha.com › symbol › XLO

   • Cached

   4 days ago · A high-level overview of Xilio Therapeutics, Inc. (XLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

9. www.wsj.com › market-data › quotesXLO | Xilio Therapeutics Inc. Stock Price & News - WSJ

   www.wsj.com › market-data › quotes

   • Cached

   View the latest Xilio Therapeutics Inc. (XLO) stock price, news, historical charts, analyst ratings and financial information from WSJ.